0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Protein Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: October 2024
|
Report Code: QYRE-Auto-38B2538
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Protein Drugs Market Insights and Forecast to 2028
BUY CHAPTERS

Protein Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-38B2538
Report
October 2024
Pages:107
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Protein Drugs - Market Size

The global market for Protein Drugs was estimated to be worth US$ 266900 million in 2023 and is forecast to a readjusted size of US$ 439710 million by 2030 with a CAGR of 7.3% during the forecast period 2024-2030

Protein Drugs - Market

Protein Drugs - Market

A type of drugs made of protein. These drugs usually have large molecular weight with proteincharacteristics.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Protein Drugs, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Protein Drugs by region & country, by Type, and by Application.
The Protein Drugs market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Protein Drugs.
Market Segmentation

Scope of Protein Drugs - Market Report

Report Metric Details
Report Name Protein Drugs - Market
Forecasted market size in 2030 US$ 439710 million
CAGR 7.3%
Forecasted years 2024 - 2030
Segment by Type:
  • Antibody Drugs
  • Peptide Hormones
  • Blood Products
  • Enzymes
Segment by Application
  • Hospitals
  • Clinics
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Eli Lilly, Abbott Laboratories, UCB Group, Schering-Plough Corporation, Genentech, Johnson&Johnson, Bristol-Myers Squibb, Novo Nordisk, Biogen Idec, Dendreon Corporation, Amgen Inc.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Protein Drugs manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Protein Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Protein Drugs in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Protein Drugs - Market size in 2030?

Ans: The Protein Drugs - Market size in 2030 will be US$ 439710 million.

Who are the main players in the Protein Drugs - Market report?

Ans: The main players in the Protein Drugs - Market are Eli Lilly, Abbott Laboratories, UCB Group, Schering-Plough Corporation, Genentech, Johnson&Johnson, Bristol-Myers Squibb, Novo Nordisk, Biogen Idec, Dendreon Corporation, Amgen Inc.

What are the Application segmentation covered in the Protein Drugs - Market report?

Ans: The Applications covered in the Protein Drugs - Market report are Hospitals, Clinics, Other

What are the Type segmentation covered in the Protein Drugs - Market report?

Ans: The Types covered in the Protein Drugs - Market report are Antibody Drugs, Peptide Hormones, Blood Products, Enzymes

1 Market Overview
1.1 Protein Drugs Product Introduction
1.2 Global Protein Drugs Market Size Forecast
1.3 Protein Drugs Market Trends & Drivers
1.3.1 Protein Drugs Industry Trends
1.3.2 Protein Drugs Market Drivers & Opportunity
1.3.3 Protein Drugs Market Challenges
1.3.4 Protein Drugs Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Protein Drugs Players Revenue Ranking (2023)
2.2 Global Protein Drugs Revenue by Company (2019-2024)
2.3 Key Companies Protein Drugs Manufacturing Base Distribution and Headquarters
2.4 Key Companies Protein Drugs Product Offered
2.5 Key Companies Time to Begin Mass Production of Protein Drugs
2.6 Protein Drugs Market Competitive Analysis
2.6.1 Protein Drugs Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Protein Drugs Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Protein Drugs as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Antibody Drugs
3.1.2 Peptide Hormones
3.1.3 Blood Products
3.1.4 Enzymes
3.2 Global Protein Drugs Sales Value by Type
3.2.1 Global Protein Drugs Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Protein Drugs Sales Value, by Type (2019-2030)
3.2.3 Global Protein Drugs Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Clinics
4.1.3 Other
4.2 Global Protein Drugs Sales Value by Application
4.2.1 Global Protein Drugs Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Protein Drugs Sales Value, by Application (2019-2030)
4.2.3 Global Protein Drugs Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Protein Drugs Sales Value by Region
5.1.1 Global Protein Drugs Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Protein Drugs Sales Value by Region (2019-2024)
5.1.3 Global Protein Drugs Sales Value by Region (2025-2030)
5.1.4 Global Protein Drugs Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Protein Drugs Sales Value, 2019-2030
5.2.2 North America Protein Drugs Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Protein Drugs Sales Value, 2019-2030
5.3.2 Europe Protein Drugs Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Protein Drugs Sales Value, 2019-2030
5.4.2 Asia Pacific Protein Drugs Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Protein Drugs Sales Value, 2019-2030
5.5.2 South America Protein Drugs Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Protein Drugs Sales Value, 2019-2030
5.6.2 Middle East & Africa Protein Drugs Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Protein Drugs Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Protein Drugs Sales Value
6.3 United States
6.3.1 United States Protein Drugs Sales Value, 2019-2030
6.3.2 United States Protein Drugs Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Protein Drugs Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Protein Drugs Sales Value, 2019-2030
6.4.2 Europe Protein Drugs Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Protein Drugs Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Protein Drugs Sales Value, 2019-2030
6.5.2 China Protein Drugs Sales Value by Type (%), 2023 VS 2030
6.5.3 China Protein Drugs Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Protein Drugs Sales Value, 2019-2030
6.6.2 Japan Protein Drugs Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Protein Drugs Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Protein Drugs Sales Value, 2019-2030
6.7.2 South Korea Protein Drugs Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Protein Drugs Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Protein Drugs Sales Value, 2019-2030
6.8.2 Southeast Asia Protein Drugs Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Protein Drugs Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Protein Drugs Sales Value, 2019-2030
6.9.2 India Protein Drugs Sales Value by Type (%), 2023 VS 2030
6.9.3 India Protein Drugs Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Eli Lilly
7.1.1 Eli Lilly Profile
7.1.2 Eli Lilly Main Business
7.1.3 Eli Lilly Protein Drugs Products, Services and Solutions
7.1.4 Eli Lilly Protein Drugs Revenue (US$ Million) & (2019-2024)
7.1.5 Eli Lilly Recent Developments
7.2 Abbott Laboratories
7.2.1 Abbott Laboratories Profile
7.2.2 Abbott Laboratories Main Business
7.2.3 Abbott Laboratories Protein Drugs Products, Services and Solutions
7.2.4 Abbott Laboratories Protein Drugs Revenue (US$ Million) & (2019-2024)
7.2.5 Abbott Laboratories Recent Developments
7.3 UCB Group
7.3.1 UCB Group Profile
7.3.2 UCB Group Main Business
7.3.3 UCB Group Protein Drugs Products, Services and Solutions
7.3.4 UCB Group Protein Drugs Revenue (US$ Million) & (2019-2024)
7.3.5 Schering-Plough Corporation Recent Developments
7.4 Schering-Plough Corporation
7.4.1 Schering-Plough Corporation Profile
7.4.2 Schering-Plough Corporation Main Business
7.4.3 Schering-Plough Corporation Protein Drugs Products, Services and Solutions
7.4.4 Schering-Plough Corporation Protein Drugs Revenue (US$ Million) & (2019-2024)
7.4.5 Schering-Plough Corporation Recent Developments
7.5 Genentech
7.5.1 Genentech Profile
7.5.2 Genentech Main Business
7.5.3 Genentech Protein Drugs Products, Services and Solutions
7.5.4 Genentech Protein Drugs Revenue (US$ Million) & (2019-2024)
7.5.5 Genentech Recent Developments
7.6 Johnson&Johnson
7.6.1 Johnson&Johnson Profile
7.6.2 Johnson&Johnson Main Business
7.6.3 Johnson&Johnson Protein Drugs Products, Services and Solutions
7.6.4 Johnson&Johnson Protein Drugs Revenue (US$ Million) & (2019-2024)
7.6.5 Johnson&Johnson Recent Developments
7.7 Bristol-Myers Squibb
7.7.1 Bristol-Myers Squibb Profile
7.7.2 Bristol-Myers Squibb Main Business
7.7.3 Bristol-Myers Squibb Protein Drugs Products, Services and Solutions
7.7.4 Bristol-Myers Squibb Protein Drugs Revenue (US$ Million) & (2019-2024)
7.7.5 Bristol-Myers Squibb Recent Developments
7.8 Novo Nordisk
7.8.1 Novo Nordisk Profile
7.8.2 Novo Nordisk Main Business
7.8.3 Novo Nordisk Protein Drugs Products, Services and Solutions
7.8.4 Novo Nordisk Protein Drugs Revenue (US$ Million) & (2019-2024)
7.8.5 Novo Nordisk Recent Developments
7.9 Biogen Idec
7.9.1 Biogen Idec Profile
7.9.2 Biogen Idec Main Business
7.9.3 Biogen Idec Protein Drugs Products, Services and Solutions
7.9.4 Biogen Idec Protein Drugs Revenue (US$ Million) & (2019-2024)
7.9.5 Biogen Idec Recent Developments
7.10 Dendreon Corporation
7.10.1 Dendreon Corporation Profile
7.10.2 Dendreon Corporation Main Business
7.10.3 Dendreon Corporation Protein Drugs Products, Services and Solutions
7.10.4 Dendreon Corporation Protein Drugs Revenue (US$ Million) & (2019-2024)
7.10.5 Dendreon Corporation Recent Developments
7.11 Amgen Inc.
7.11.1 Amgen Inc. Profile
7.11.2 Amgen Inc. Main Business
7.11.3 Amgen Inc. Protein Drugs Products, Services and Solutions
7.11.4 Amgen Inc. Protein Drugs Revenue (US$ Million) & (2019-2024)
7.11.5 Amgen Inc. Recent Developments
8 Industry Chain Analysis
8.1 Protein Drugs Industrial Chain
8.2 Protein Drugs Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Protein Drugs Sales Model
8.5.2 Sales Channel
8.5.3 Protein Drugs Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Protein Drugs Market Trends
    Table 2. Protein Drugs Market Drivers & Opportunity
    Table 3. Protein Drugs Market Challenges
    Table 4. Protein Drugs Market Restraints
    Table 5. Global Protein Drugs Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Protein Drugs Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Protein Drugs Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Protein Drugs Product Type
    Table 9. Key Companies Time to Begin Mass Production of Protein Drugs
    Table 10. Global Protein Drugs Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Protein Drugs as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Protein Drugs Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Protein Drugs Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Protein Drugs Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Protein Drugs Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Protein Drugs Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Protein Drugs Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Protein Drugs Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Protein Drugs Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Protein Drugs Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Protein Drugs Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Protein Drugs Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Protein Drugs Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Protein Drugs Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Protein Drugs Sales Value by Region (2019-2024) & (%)
    Table 27. Global Protein Drugs Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Protein Drugs Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Protein Drugs Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Protein Drugs Sales Value, (2025-2030) & (US$ Million)
    Table 31. Eli Lilly Basic Information List
    Table 32. Eli Lilly Description and Business Overview
    Table 33. Eli Lilly Protein Drugs Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Protein Drugs Business of Eli Lilly (2019-2024)
    Table 35. Eli Lilly Recent Developments
    Table 36. Abbott Laboratories Basic Information List
    Table 37. Abbott Laboratories Description and Business Overview
    Table 38. Abbott Laboratories Protein Drugs Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Protein Drugs Business of Abbott Laboratories (2019-2024)
    Table 40. Abbott Laboratories Recent Developments
    Table 41. UCB Group Basic Information List
    Table 42. UCB Group Description and Business Overview
    Table 43. UCB Group Protein Drugs Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Protein Drugs Business of UCB Group (2019-2024)
    Table 45. UCB Group Recent Developments
    Table 46. Schering-Plough Corporation Basic Information List
    Table 47. Schering-Plough Corporation Description and Business Overview
    Table 48. Schering-Plough Corporation Protein Drugs Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Protein Drugs Business of Schering-Plough Corporation (2019-2024)
    Table 50. Schering-Plough Corporation Recent Developments
    Table 51. Genentech Basic Information List
    Table 52. Genentech Description and Business Overview
    Table 53. Genentech Protein Drugs Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Protein Drugs Business of Genentech (2019-2024)
    Table 55. Genentech Recent Developments
    Table 56. Johnson&Johnson Basic Information List
    Table 57. Johnson&Johnson Description and Business Overview
    Table 58. Johnson&Johnson Protein Drugs Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Protein Drugs Business of Johnson&Johnson (2019-2024)
    Table 60. Johnson&Johnson Recent Developments
    Table 61. Bristol-Myers Squibb Basic Information List
    Table 62. Bristol-Myers Squibb Description and Business Overview
    Table 63. Bristol-Myers Squibb Protein Drugs Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Protein Drugs Business of Bristol-Myers Squibb (2019-2024)
    Table 65. Bristol-Myers Squibb Recent Developments
    Table 66. Novo Nordisk Basic Information List
    Table 67. Novo Nordisk Description and Business Overview
    Table 68. Novo Nordisk Protein Drugs Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Protein Drugs Business of Novo Nordisk (2019-2024)
    Table 70. Novo Nordisk Recent Developments
    Table 71. Biogen Idec Basic Information List
    Table 72. Biogen Idec Description and Business Overview
    Table 73. Biogen Idec Protein Drugs Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Protein Drugs Business of Biogen Idec (2019-2024)
    Table 75. Biogen Idec Recent Developments
    Table 76. Dendreon Corporation Basic Information List
    Table 77. Dendreon Corporation Description and Business Overview
    Table 78. Dendreon Corporation Protein Drugs Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Protein Drugs Business of Dendreon Corporation (2019-2024)
    Table 80. Dendreon Corporation Recent Developments
    Table 81. Amgen Inc. Basic Information List
    Table 82. Amgen Inc. Description and Business Overview
    Table 83. Amgen Inc. Protein Drugs Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Protein Drugs Business of Amgen Inc. (2019-2024)
    Table 85. Amgen Inc. Recent Developments
    Table 86. Key Raw Materials Lists
    Table 87. Raw Materials Key Suppliers Lists
    Table 88. Protein Drugs Downstream Customers
    Table 89. Protein Drugs Distributors List
    Table 90. Research Programs/Design for This Report
    Table 91. Key Data Information from Secondary Sources
    Table 92. Key Data Information from Primary Sources
    Table 93. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Protein Drugs Product Picture
    Figure 2. Global Protein Drugs Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Protein Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 4. Protein Drugs Report Years Considered
    Figure 5. Global Protein Drugs Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Protein Drugs Revenue in 2023
    Figure 7. Protein Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Antibody Drugs Picture
    Figure 9. Peptide Hormones Picture
    Figure 10. Blood Products Picture
    Figure 11. Enzymes Picture
    Figure 12. Global Protein Drugs Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 13. Global Protein Drugs Sales Value Market Share by Type, 2023 & 2030
    Figure 14. Product Picture of Hospitals
    Figure 15. Product Picture of Clinics
    Figure 16. Product Picture of Other
    Figure 17. Global Protein Drugs Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 18. Global Protein Drugs Sales Value Market Share by Application, 2023 & 2030
    Figure 19. North America Protein Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 20. North America Protein Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 21. Europe Protein Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 22. Europe Protein Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 23. Asia Pacific Protein Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 24. Asia Pacific Protein Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 25. South America Protein Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 26. South America Protein Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 27. Middle East & Africa Protein Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 28. Middle East & Africa Protein Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 29. Key Countries/Regions Protein Drugs Sales Value (%), (2019-2030)
    Figure 30. United States Protein Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 31. United States Protein Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 32. United States Protein Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 33. Europe Protein Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 34. Europe Protein Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 35. Europe Protein Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 36. China Protein Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 37. China Protein Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 38. China Protein Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 39. Japan Protein Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 40. Japan Protein Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 41. Japan Protein Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 42. South Korea Protein Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 43. South Korea Protein Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 44. South Korea Protein Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 45. Southeast Asia Protein Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 46. Southeast Asia Protein Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 47. Southeast Asia Protein Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 48. India Protein Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 49. India Protein Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 50. India Protein Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 51. Protein Drugs Industrial Chain
    Figure 52. Protein Drugs Manufacturing Cost Structure
    Figure 53. Channels of Distribution (Direct Sales, and Distribution)
    Figure 54. Bottom-up and Top-down Approaches for This Report
    Figure 55. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS